Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Cangene's recombinant human growth hormone approved by the FDA

Jan. 28, 2008

Patient enrollment begins for NIH funded SFP clinical study

Jan. 28, 2008

Regulatory T-cell loss of function triggers type 1 diabetes in mice

Jan. 28, 2008

Nissan Chemical patents novel antithrombocytopenic compounds

Jan. 28, 2008

Mochida launches Dinagest Tab. 1 mg in Japan for endometriosis indication

Jan. 25, 2008

Dosing begins for U.S. phase I study of Hematide in chemotherapy-induced anemia

Jan. 25, 2008

Genaera's diabetes IND in effect for trodusquemine

Jan. 25, 2008

Tercica initiates phase II next-generation growth hormone trial

Jan. 25, 2008

Oramed commences phase Ib oral insulin trial

Jan. 25, 2008

New antidiabetic agents described in recent patents

Jan. 25, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...